ArticleExperimental and therapeutic medicine2016

Knockdown of KLK11 inhibits cell proliferation and increases oxaliplatin sensitivity in human colorectal cancer.

Zongbin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.